The CMSC is pleased to offer our pharmaceutical partners the opportunity to present live educational webinars focused on specific disease-modifying therapies and disease state management in multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and other Rare Disease. Developed by our industry partners, these evidence-based programs provide timely updates on specific therapies and approaches to optimize patient outcomes. Each session is designed for healthcare professionals and delivers expert insights to support informed, patient-centered care.

Industry Partner Obligations:

Content creations, review, and promotion

Speakers outreach, contracting, and payments

Reporting to health authorities as needed

CMSC Obligations

Third party web platform contracting and execution

Webinar moderation

Audience generation

Communications

Metrics reporting following each webinar and cumulative at the end of programming

Audience generation deliverables include:

Email blast sent to CMSC mailing list of 12,000+ clinicians

Info and link to registration on CMSC/IOMSN website

Extensive social media promotion to more than 3,500 followers across all social platforms

Optional: Consider delivering a live webinar multiple times to accommodate time zones
Download Flyer

HIGHLIGHTS

Full content control – Use your own slide deck

Speaker choice – Choose the clinical experts for your program

Qualified HCP Audience – 12,000+ clinicians (Physicians, Nurses, NPs, PAs, Rehab and Mental Health Professionals)

Extensive promotion - Advertising through CMSC/IOMSN websites and social media

Dedicated program webpage - Info and link to registration on dedicated page on the CMSC/IOMSN website

Professional presentation - CMSC/IOMSN information disclaimer on Registration, the webpage and slides

Measurable results - Participation metrics will be provided after each webinar

Post-event engagement - A follow-up email will be sent to all participants